Skip to main content

Granisetron Hydrochloride Injection Shortage

Last Updated: December 3, 2018
Status: Resolved

Reason for the Shortage
    • Akorn did not provide a reason for the shortage.
    • Fresenius Kabi did not provide a reason for the shortage.
    • Hikma did not provide a reason for the shortage.
Available Products
    • Granisetron Hydrochloride intravenous injection, Akorn, 1 mg/mL, 1 mL vial, 1 count, NDC 17478-0546-02
    • Granisetron Hydrochloride intravenous injection, Akorn, 1 mg/mL, 4 mL multiple dose vial, 1 count, NDC 17478-0546-05
    • Granisetron Hydrochloride intravenous injection, Fresenius Kabi, 0.1 mg/mL, 1 mL single dose vial, 10 count, NDC 63323-0317-01
    • Granisetron Hydrochloride intravenous injection, Fresenius Kabi, 1 mg/mL, 1 mL single dose vial, 1 count, NDC 63323-0318-01
    • Granisetron Hydrochloride intravenous injection, Fresenius Kabi, 1 mg/mL, 4 mL multiple dose vial, 1 count, NDC 63323-0319-04
    • Granisetron Hydrochloride intravenous injection, Hikma, 1 mg/mL, 1 mL single dose vial, 10 count, NDC 00143-9744-10
    • Granisetron Hydrochloride intravenous injection, Hikma, 1 mg/mL, 4 mL multiple dose vial, 10 count, NDC 00143-9745-05
    • Granisetron Hydrochloride intravenous injection, Mylan, 1 mg/mL, 1 mL single dose vial, 1 count, NDC 67457-0863-01
    • Granisetron Hydrochloride intravenous injection, Mylan, 1 mg/mL, 4 mL multiple dose vial, 1 count, NDC 67457-0864-04

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated December 3, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created May 23, 2018 by Leslie Jensen, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer